Cosyntropin vs hGHRH(1-44)
Head-to-head comparison of Cosyntropin (Cosyntropin (ACTH 1-24)) and hGHRH(1-44) (Human growth hormone-releasing hormone (1-44) amide) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Cosyntropin | hGHRH(1-44) |
|---|---|---|
| Category | Pain Management | Growth Hormone |
| Full Name | Cosyntropin (ACTH 1-24) | Human growth hormone-releasing hormone (1-44) amide |
| Molecular Weight | 2933.3 Da | N/A |
| Half-Life | ~10 min | 5-15 minutes |
| Amino Acids | 24 | 44 |
| Typical Dose | 0.25 mg IV/IM diagnostic dose|off-label headache protocols vary | 0.1-1 mcg/kg |
| Route | IV|IM | Subcutaneous/IV |
| Purity | ≥98% | ≥98% |
| Studies Count | 61 | 120 |
| Research Status | Clinical research | Clinical Research |
Cosyntropin Benefits
- ✓refractory migraine
- ✓anti-inflammatory signaling
- ✓headache rescue research
hGHRH(1-44) Benefits
- ✓physiologic GH pulse support
- ✓IGF-1 pathway stimulation
- ✓pituitary receptor mapping
- ✓endocrine research tool
Cosyntropin Dosing
0.25 mg IV/IM|1 mg IV/IM
hGHRH(1-44) Dosing
0.1-1 mcg/kg SC or IV bolus for stimulation studies|single-dose endocrine challenge with timed GH sampling|pulsatile administration in clamp/infusion experiments
Cosyntropin Side Effects
- ⚠flushing
- ⚠nausea
hGHRH(1-44) Side Effects
- ⚠flushing
- ⚠headache
- ⚠transient nausea
Research Overview
Cosyntropin
Cosyntropin is not a standard pain drug, but it appears in headache literature because ACTH analogs can help some patients with difficult migraine attacks. The analgesic rationale is partly tied to steroidogenic and anti-inflammatory effects.
hGHRH(1-44)
Human GHRH(1-44) amide has been used extensively to characterize hypothalamic control of pituitary somatotrophs and the downstream GH/IGF-1 axis. It remains a standard comparator in studies of GHRH agonism, secretion dynamics, and receptor pharmacology.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.